BrainsWay Ltd.

BWAY | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.34

-$0.23 (-1.69%)

Sep 22, 2026, 11:03 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.69%

(1D)

Rating

Updated: Aug 28, 2026

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $523.23M

1D Range

13.02 13.46

52W Range

7.14 17.40

Valuation (TTM)

PE 30.84

PB 6.72

EV/EBITDA 39.16

Valuation (NTM)

Forward PE 49.54

Forward PEG -0.56

Price Target $19.50

Cash Flow

FCF Yield 1.1%

SBC Adj. FCF Yield 0.9%

SBC Impact -17.3%

Margins

Gross Margin 75.3%

Operating Margin 12.5%

FCF Margin 9.3%

Growth (CAGR)

Revenue 3Y | 5Y 33.5% | 18.4%

Dil EPS 3Y | 5Y 103.1% | 8894.2%

FCF 3Y | 5Y -0.7% | 126.2%

Returns

ROA 7.8%

ROE 12.7%

ROIC 7.7%

Financial Health

Net Cash

$61.12M

Current Ratio 3.59

Interest Coverage 3.59

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presen...

Sector Healthcare

Industry Medical - Specialties

Employees 129

IPO Date Apr 16, 2019

Website www.brainsway.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 10, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$19.50

Upside

+46.18%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞